According to Immuno-Biological Laboratories latest financial reports the total debt is $696.91K, an decrease of -5.61% to 2022. At the end of 2022 company had $738.33K total debt. This figure represents the debts and financial obligations that Immuno-Biological Laboratories combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $696.91K | -5.61% |
2022 | $738.33K | 77.95% |
2021 | $414.91K | 195.00% |
2020 | $140.65K | -93.01% |
2019 | $2.01M | - |